Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2010 Jun 7;28(20):3256–3263. doi: 10.1200/JCO.2009.24.4244

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2010 by American Society of Clinical Oncology

PMC Copyright notice

Fig 3. — (A) Investigator review of the progression-free survival (PFS) Kaplan-Meier curves. PFS distribution for patients with measurable disease receiving ixabepilone combination (I + C) versus capecitabine alone (C) are shown. (B) PFS hazard ratio (HR) and 95% CI for subset analyses. HRs less than 1 favor combination therapy. KPS, Karnofsky performance status; Mod, moderate; Sev, severe; chemo, chemotherapy; HER2, human epidermal growth factor receptor 2; ER, estrogen receptor; PR, progesterone receptor.